CN116354873A - Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof - Google Patents

Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof Download PDF

Info

Publication number
CN116354873A
CN116354873A CN202310245400.8A CN202310245400A CN116354873A CN 116354873 A CN116354873 A CN 116354873A CN 202310245400 A CN202310245400 A CN 202310245400A CN 116354873 A CN116354873 A CN 116354873A
Authority
CN
China
Prior art keywords
formula
ligand
compound
compound shown
tetradentate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310245400.8A
Other languages
Chinese (zh)
Inventor
李湘黔
马爽
杨佩瑛
张宇燕
孙颢瑄
于秋寒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pingdingshan University
Original Assignee
Pingdingshan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pingdingshan University filed Critical Pingdingshan University
Priority to CN202310245400.8A priority Critical patent/CN116354873A/en
Publication of CN116354873A publication Critical patent/CN116354873A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/28Titanium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)

Abstract

The invention provides a pyridine-derived tetradentate dianion ligand intermediate, a ligand and a preparation method thereof, wherein the ligand compound intermediate has a structure shown as a formula TS-1
Figure DDA0004125830590000011
The compound shown in the formula TS-1 can be used as a raw material to synthesize a novel transition metal nitrogen-containing tetradentate dianion ligand, the synthesis scheme is feasible, and the method is conventional and simple, and the ligand can play an important role in the construction of metal-ligand bonding and multiple bonds.

Description

Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof
Technical Field
The invention belongs to the field of compound synthesis, and particularly relates to a novel pyridine-derived tetradentate dianion ligand compound intermediate, a ligand and a preparation method thereof.
Background
In recent years, reports on transition metal organic compounds have been increasing, and various types of ligands have been reported successively. However, compared with monodentate or bidentate ligands, the polydentate ligand not only can reduce coordination number of metal, but also can eliminate the phenomenon of hierarchical coordination and enhance stability of the complex. However, the types of such multidentate ligands are relatively few, and the ligands reported previously comprise a flexible, perfluorinated ligand and derivatives thereof (e.g., formula A), and a class of rigid, flexible, and economical "N 2 O 2 "ligand (formula B)" which forms neutral, cationic and multiple bond complexes with transition metals.
Figure BDA0004125830420000011
However, polydentate chelating total nitrogen ligands having both rigid and flexible properties have not been reported, and nitrogen may be modified by substitution of various substituents; therefore, the design of the multidentate chelate nitrogen-containing ligand stable transition metal with the combination of hardness and softness has very important significance. It is now desirable to provide a novel method for synthesizing nitrogen-containing tetradentate ligands, which is simple, has few steps, and is easy to post-treat, and which is useful for bonding with transition metals.
Disclosure of Invention
The invention provides a novel pyridine modified nitrogen-containing tetradentate dianion ligand and an intermediate thereof, and a preparation method thereof is illustrated, and the preparation method is simple, has fewer steps and is easy to post-treat.
One of the purposes of the present invention is to provide a pyridine-derived tetradentate dianion ligand intermediate having a structure as shown in formula TS-1:
Figure BDA0004125830420000021
the present inventors have unexpectedly discovered a novel pyridine-modified nitrogen-containing tetradentate dianion ligand intermediate in a number of studies and experiments. The invention takes the ligand intermediate shown in the formula TS-1 as a raw material, can prepare novel transition metal organic complexes, and plays an important role in the construction of metal-ligand bonding and multiple bonds.
The invention also aims at providing a novel pyridine modified nitrogen-containing tetradentate dianion ligand, which has a structure shown in a general formula (I):
Figure BDA0004125830420000022
according to some preferred embodiments of the invention, R is LiNSi i Pr 3 The ligand compound has a structure shown in a formula 4:
Figure BDA0004125830420000023
the invention also provides a preparation method of the ligand intermediate, which comprises the following steps:
Figure BDA0004125830420000031
step 1: reacting 2-aminomethylpyridine with o-nitrobenzyl bromide to obtain an intermediate product shown in a formula 3;
step 2: and reducing the intermediate product shown in the formula 3 by stannous chloride and methanol to obtain the compound shown in the formula TS-1.
In the above-mentioned intermediate synthesis method of the present invention, the compound represented by formula 3 may also be prepared by other methods available in the art, and the synthesis route of the above two steps is a preferred synthesis route of the compound represented by formula TS-1 of the present invention. The compound of the formula TS-1 adopts the synthesis route and has the advantages of short synthesis steps, high reaction yield, no need of column chromatography separation and the like.
The preferred preparation method of the compound shown in the formula TS-1 comprises the following steps:
step 1: adding 2-aminomethylpyridine, o-nitrobenzyl bromide and cesium carbonate into a solvent for heating reaction to obtain an intermediate product shown in a formula 3;
step 2: adding the intermediate product shown in the formula 3 and stannous chloride into absolute methanol, heating for reaction, filtering, extracting and drying to obtain a compound shown in the formula TS-1;
preferably, in step 1, the solvent is DMF; preferably, the proportion of the 2-aminomethylpyridine, the o-nitrobenzyl bromide and the cesium carbonate added to the DMF is 10 g:20-60 g:30-60 g:100-500 mL; the reaction is carried out for 24 hours at 80 ℃.
In the step 2, the ratio of the compound shown in the formula 3 to stannous chloride to methanol is 10 g:60-100 g:100-500 mL; the step is to heat and react for 6 to 24 hours at the temperature of 40 to 100 ℃.
It is a further object of the present invention to provide a process for the preparation of said ligands,
Figure BDA0004125830420000032
comprises the step of preparing a compound shown in a formula I by nucleophilic substitution reaction and lithiation reaction of nitrogen by taking the compound shown in the formula TS-1 as a raw material, wherein R is NLiSi i Pr 3
The invention provides a synthesis process of a novel ligand compound, which takes the intermediate as a raw material to synthesize a novel transition metal nitrogen-containing tetradentate ligand, and has the advantages of simple synthesis steps, high reaction yield and no need of column chromatography separation.
A preferred embodiment of the process for the preparation of the compounds of formula 4 according to the invention is:
Figure BDA0004125830420000041
the method comprises the steps of (1) taking a compound shown in a formula TS-1 and triisopropylchlorosilane as raw materials, and carrying out nucleophilic substitution reaction and lithiation reaction to obtain a compound shown in a formula 4;
the method comprises the following steps: mixing a compound shown in a formula TS-1 with an ultra-dry tetrahydrofuran solution under a protective gas, firstly dripping n-butyllithium at a temperature of between minus 30 and minus 80 ℃ for 2 to 12 hours, then dripping triisopropylchlorosilane, draining the solvent, extracting the remainder with n-hexane for 1 to 3 times, dripping n-butyllithium again for 2 to 12 hours, and obtaining the compound shown in a formula 4;
more preferably, the ratio of the compound shown in the formula TS-1, THF, the first added n-butyllithium, triisopropylchlorosilane and the second added n-butyllithium is 1 g:5-10 mL:2-6 mL:1-4 g:2-6 mL, wherein the concentration of the n-butyllithium is 2.5mol/L.
In the invention, the method for synthesizing the novel nitrogen-containing tetradentate ligand by taking the compound shown in TS-1 as the raw material has the advantages of simple synthesis steps, high reaction yield and no need of column chromatography separation.
It is still another object of the present invention to provide a transition metal organic complex which is prepared by bonding the ligand compound with a transition metal; preferably, the transition metal is elemental titanium.
The preparation method of the transition metal organic complex provided by the invention comprises the following steps:
under the protection gas, adding the compound shown in the formula 4 into a Schlenk bottle, and adding ultra-dry THF to dissolve the compound shown in the formula 4; tiCl was introduced into another Schlenk bottle 4 (THF) 2 And THF; at-78 ℃, the TiCl is reacted with the catalyst 4 (THF) 2 The solution is pressurized and introduced into the THF solution of the compound shown in the formula 4, stirred for 6 to 20 hours, gradually recovered to room temperature, the solvent is pumped out, the complex is extracted by toluene, and the dichloro complex of Ti is obtained after volatilization and cooling. Mixing the Ti dichloro complex and sodium azide under the protection gas, adding ultra-dry THF, stirring for 6-20 h, pumping the solvent, extracting the complex by toluene, volatilizing and cooling to obtain the Ti bis-azide complex.
The invention has the advantages that:
the invention provides a novel pyridine modified nitrogen-containing tetradentate dianion ligand intermediate and a ligand, wherein the ligand can form a bond with transition metal titanium, and the tetradentate ligand has rigidity and flexibility compared with the ligand reported before, can form a novel transition metal organic complex, and plays an important role in the construction of metal-ligand bond and multiple bonds.
Drawings
FIG. 1 is a schematic diagram of the hydrogen spectrum of the intermediate shown in formula 3
FIG. 2 is a schematic carbon spectrum of the intermediate shown in formula 3
FIG. 3 is a schematic diagram of the hydrogen spectrum of the intermediate product of formula TS-1
FIG. 4 is a schematic carbon spectrum of an intermediate of formula TS-1
FIG. 5 is a schematic diagram of the hydrogen spectrum of the intermediate shown in formula 4
FIG. 6 is a schematic diagram of the crystal structure of the intermediate shown in formula 5.
FIG. 7 is a schematic diagram of the crystal structure of the product of formula 6.
Detailed Description
The following examples further illustrate the invention but are not to be construed as limiting the invention. Modifications and substitutions to methods, procedures, or conditions of the present invention without departing from the spirit and nature of the invention are intended to be within the scope of the present invention.
The technical means used in the examples are conventional means well known to those skilled in the art unless otherwise indicated. In the examples, the raw materials added are all commercially available conventional raw materials unless otherwise specified; THF, n-hexane and toluene are subjected to anhydrous and anaerobic treatment by heavy evaporation; the concentration of the n-butyllithium is 2.5mol/L; in the following examples, the protective gas was carried out under a nitrogen atmosphere, and in the following examples, the yield was obtained according to the following formula: yield = actual product mass/theoretical product mass 100%; part of the compounds are detected by a Bruce 400M nuclear magnetic resonance analyzer, part of the compounds are detected by a Bruce ESI-MS mass spectrometer, and part of the compounds are detected by a Bruce single crystal diffractometer.
EXAMPLE 1 preparation of pyridine-derived tetradentate dianion ligand intermediate
Figure BDA0004125830420000061
(1) Synthesis of intermediate of formula 3:
10.8g of raw material 2-aminomethylpyridine, 42.8g of o-nitrobenzyl bromide and 55.2g of cesium carbonate are added into a 500mL single-neck flask, 300mL of DMF is added, heating is carried out for 24h at 80 ℃, cooling is carried out to room temperature, 300mL of water is added, extraction is carried out three times with ethyl acetate (200 mL. Times.3), drying and spin drying are carried out, and recrystallization is carried out by using methylene dichloride, filtration and vacuum drying are carried out to obtain 32g of pale yellow solid with the yield of 85%. ESI-MS (+Na) + ):401; 1 H-NMR(CDCl 3 ;400MHz)δ8.43(d,J=4.9Hz,1H),7.71(d,J=7.7Hz,2H),7.59-7.54(m,3H),7.45(t,J=7.7Hz,2H),7.27(t,J=7.7Hz,2H),7.18(t,J=6.9Hz,1H),7.07(dd,J=7.7Hz,J=4.9Hz,1H),3.92(s,4H),3.65(s,2H). 13 C-NMR(CDCl 3 The method comprises the steps of carrying out a first treatment on the surface of the 100 MHz): delta 157.9,150.0,149.2,136.6,134.1,132.8,131.4,128.2,124.5,123.6,122.5,60.8,55.7. The nuclear magnetic hydrogen spectrum and the carbon spectrum of the product obtained in this step are shown in FIGS. 1 and 2, respectively. The product obtained in the step is an intermediate product shown in a formula 3.
(2) Synthesis of compounds of formula TS-1:
10.0g of intermediate shown in formula 3, 80.0g of stannous chloride and 250mL of methanol are added into a 500mL single-neck flask, the mixture is heated and refluxed for 6 hours at 100 ℃, cooled to room temperature, filtered by kieselguhr, dried by spinning, recrystallized by anhydrous methanol, filtered and dried in vacuum to obtain 3.10g of pale yellow solid with 97 percent yield. ESI-MS (+Na) + ):341; 1 H-NMR(CDCl 3 ;400MHz)δ8.48-8.47(m,1H),7.54-7.50(m,1H),7.09-7.08(m,2H),7.00-6.98(m,4H),6.57(t,J=6.9Hz,2H),6.49(d,J=7.9Hz,2H),4.62(s,4H),3.62(s,2H),3.51(s,4H). 13 C-NMR(CDCl 3 The method comprises the steps of carrying out a first treatment on the surface of the 400 MHz) delta 159.4,149.3,146.7,136.6,131.7,128.9,123.7,122.3,122.2,117.5,115.8,59.6,58.1, the nuclear magnetic hydrogen spectrum and the carbon spectrum of the product obtained in this step are shown in fig. 3 and 4, respectively. The product obtained in the step is the compound shown in the formula TS-1.
EXAMPLE 2 Synthesis of Compound of formula 4
Figure BDA0004125830420000071
Under the protection of gas, 1.0g of TS-1The compound was added to a 50mL Schlenk flask, 6mL THF was added thereto, 2.5mol/L n-butyllithium was added dropwise at-78℃for reaction for 6 hours, and 1.21g triisopropylchlorosilane was added dropwise at-78℃for reaction for 12 hours. The solution was drained, extracted 2 times with 30mL of n-hexane, and 2.5mol/L of n-butyllithium 2.52mL was added dropwise at-78℃and reacted for 12 hours. Then filtered, drained, washed 1 time with 20mL of n-hexane, and drained to give 1.64g of yellow solid in 81% yield. 1 H-NMR(C 6 D 6 400 MHz) delta 7.98 (s, 1H), 7.01 (t, j=8.0 hz, 2H), 6.93 (t, j=8.0 hz, 2H), 6.85-6.82 (m, 1H), 6.65-6.63 (m, 2H), 6.48-6.35 (m, 4H), 3.54-3.51 (m, 6H), 1.34-1.30 (m, 6H), 1.22 (s, 18H), 1.21 (s, 18H). The product obtained in the step is the compound shown in the formula 4.
Example 3
Figure BDA0004125830420000072
(1) Synthesis of intermediate of formula 5:
under inert gas, 1.93g of the compound represented by formula 4 was charged into a 50mL Schlenk flask, 10mL THF was further added, and then 0.97g TiCl was introduced into the other Schlenk flask 4 (THF) 2 And 10ml of THF, tiCl being introduced at-78deg.C 4 (THF) 2 Is introduced under pressure into a solution of the compound represented by formula 4, stirred for 6 hours, returned to room temperature, dried by suction, extracted with toluene, cooled to give reddish brown crystals, and filtered to give 1.52g of the product in 68% yield. The specific crystal structure of the product obtained in this step is shown in fig. 6. The product obtained in the step is the compound shown in the formula 5.
(2) Synthesis of the product of formula 6:
under the protection of inert gas, 0.75g of a compound shown in a formula 5 and 0.2g of sodium azide are added into a 25mL Schlenk bottle, 10mL THF is added, stirring is carried out for 12 hours, extraction is carried out by toluene, and the mixture is cooled to obtain a reddish brown crystal, and 0.57g of a product is obtained by filtration, wherein the yield is 75%. The specific crystal structure of the product obtained in this step is shown in fig. 7. The product obtained in the step is the compound shown in the formula 6.
The above-described embodiments are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention, so that all equivalent changes or modifications of the structure, characteristics and principles described in the claims should be included in the scope of the present invention.

Claims (10)

1. A pyridine-derived tetradentate dianion ligand intermediate having the structure shown in formula TS-1:
Figure FDA0004125830390000011
2. a pyridine-derived tetradentate dianion ligand, characterized by having a structure represented by general formula (I):
Figure FDA0004125830390000012
wherein R is LiNSi i Pr 3
3. A process for the preparation of a pyridine derived tetradentate dianion ligand intermediate according to claim 1, comprising the steps of:
Figure FDA0004125830390000013
step 1: reacting 2-aminomethylpyridine with o-nitrobenzyl bromide to obtain an intermediate product shown in a formula 3;
step 2: and reducing the intermediate product shown in the formula 3 by stannous chloride and methanol to obtain the compound shown in the formula TS-1.
4. A method according to claim 3, comprising the steps of:
step 1: 2-aminomethylpyridine, cesium carbonate and o-nitrobenzyl bromide are heated to react in a solvent at 80 ℃ to obtain an intermediate product shown in a formula 3;
step 2: adding the compound shown in the formula 3 and stannous chloride into absolute methanol, heating at 40-100 ℃ for reaction, filtering, extracting and drying to obtain the compound shown in the formula TS-1.
5. The method according to claim 4, wherein in step 1, the solvent is DMF; 2-aminomethylpyridine, o-nitrobenzyl bromide and cesium carbonate are added with DMF in the proportion of 10g to 20-60 g to 30-60 g to 100-500 mL;
in the step 2, the ratio of the compound shown in the formula 3 to stannous chloride to methanol is 10 g:60-100 g:100-500 mL; the step is to heat and react for 6 to 24 hours at the temperature of 40 to 100 ℃.
6. A process for preparing a ligand compound according to claim 2, wherein,
taking a compound shown in a formula TS-1 and triisopropylchlorosilane as raw materials, and carrying out nucleophilic substitution and lithiation reaction of nitrogen to prepare a compound 4;
Figure FDA0004125830390000021
7. the method according to claim 6, comprising the steps of:
and under the protection gas, mixing the compound shown in the formula TS-1 with an ultra-dry tetrahydrofuran solution, firstly dropwise adding n-butyllithium for reaction at the temperature of minus 30 to minus 80 ℃, then dropwise adding triisopropylchlorosilane, draining the solvent, extracting the remainder by using n-hexane, and dropwise adding n-butyllithium for reaction again to obtain the compound shown in the formula 4.
8. The method according to claim 7, wherein the compound represented by formula TS-1, THF, the first addition of n-butyllithium, triisopropylchlorosilane, the second addition of n-butyllithium is in a ratio of 1 g:5-10 mL:2-6 mL:1-4 g:2-6 mL, and the concentration of n-butyllithium is 2.5mol/L.
9. A transition metal organic complex, characterized in that it is prepared by bonding the ligand according to claim 2 with a transition metal, said transition metal being titanium.
10. The method for preparing a transition metal organic complex according to claim 9, comprising the steps of:
step 1: tiCl is added under the condition of shielding gas at minus 78 DEG C 4 (THF) 2 Pressurizing and introducing the solution into the solution of the compound 4, stirring and reacting, recovering to room temperature, pumping out the solvent, extracting with toluene, volatilizing and cooling to obtain the Ti dichloro complex;
step 2: mixing the Ti dichloro complex and sodium azide under the protection gas, adding ultra-dry THF, stirring for reaction, pumping the solvent, extracting with toluene, volatilizing and cooling to obtain the Ti bis-azide complex.
CN202310245400.8A 2023-03-14 2023-03-14 Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof Pending CN116354873A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310245400.8A CN116354873A (en) 2023-03-14 2023-03-14 Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310245400.8A CN116354873A (en) 2023-03-14 2023-03-14 Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof

Publications (1)

Publication Number Publication Date
CN116354873A true CN116354873A (en) 2023-06-30

Family

ID=86940097

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310245400.8A Pending CN116354873A (en) 2023-03-14 2023-03-14 Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof

Country Status (1)

Country Link
CN (1) CN116354873A (en)

Similar Documents

Publication Publication Date Title
CN110183378B (en) Nicotinamide derivative and catalytic synthesis method thereof
EP2123661A1 (en) Chiral iridium aqua complex and method for producing optically active hydroxy compound by using the same
EP2054363B1 (en) Asymmetric hydrogenation of 1,1,1-trifluoroacetone
CN110078695B (en) Quercetin derivative and preparation method thereof
CN101219988B (en) Synthesis of 4,4'disubstituted-2,2'-dipyridine
CN116354873A (en) Pyridine-derived tetradentate dianion ligand intermediate, ligand and preparation method thereof
CN104650145A (en) Chiral phosphorous ligand as well as metal catalyst containing ligand and application of chiral phosphorous ligand and catalyst
CN105085458B (en) A kind of synthetic method of coumarin derivatives
CN113754606B (en) Phenoxazine diamine derivative and/or phenothiazine diamine derivative and preparation method thereof
CN112961176B (en) Preparation method of boron-dioxygen ring neutral radical compound
CN102892773B (en) Based on the complex compound of ruthenium
JP4050294B2 (en) Optically active cobalt (II) complex
EP1899060B1 (en) Catalyst systems based on macrocyclic ligands
Selvakumar et al. Synthesis and characterization of cyclopalladated complexes of oximes by ligand-exchange method
CN108558974B (en) Preparation and application of sugar-derived nickel pyridine triazole catalyst
JP3957346B2 (en) Method for producing optically active alcohol
Sun et al. Isocyanate diinsertion into the N–H bond of the 2-pyridylamino ligand of organolanthanides
KR20200018346A (en) New catalyst compound and method for synthesizing acrlylate using the same
CN111499520B (en) Nitrogen-containing tetradentate ligand, intermediate and preparation method thereof
CN108456172A (en) A kind of chiral aza ring carbene precursor compound and its preparation method and application with benzimidazole skeleton
CN114149451B (en) Cu (copper) alloy II Binuclear complex, preparation method thereof and application of binuclear complex in catalyzing C-S coupling reaction under mechanical force
KR101554539B1 (en) Development of Method for Amide Bond Formation via Metal-Free Aerobic Oxidative Amination of Aldehydes
WO2024000877A1 (en) Preparation method for nicotine
CN113831330B (en) New method for three-step synthesis of drug molecule 3- (2-thiophene-2-methylene) hydrazinoquinoxaline-2-ketone
CN115583978A (en) Phenazine ruthenium (II) complex hexafluorophosphate for inhibiting cryptococcus as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination